Restricted accessResearch articleFirst published online 2018-10
Effects of Interaction Between DRD4 Methylation and Prenatal Maternal Stress on Methylphenidate-Induced Changes in Continuous Performance Test Performance in Youth with Attention-Deficit/Hyperactivity Disorder
Environmental factors may interact with genetic factors via the epigenetic process, and this interaction can contribute to inter-individual variability in the treatment response. The purpose of this study was to investigate the interaction effects between dopamine receptor D4 (DRD4) methylation and prenatal maternal stress on the methylphenidate (MPH) response of youth with attention-deficit/hyperactivity disorder (ADHD).
Methods:
This study was an 8-week open-label trial of MPH that included 74 ADHD youth. We investigated the associations between MPH treatment response, which was defined as a score ≤2 on the Clinical Global Impressions-Improvement (CGI-I) scale, and the methylation of 28 cytosine-guanine dinucleotide (CpG) sites of DRD4. Additionally, the interaction effects between DRD4 methylation and prenatal maternal stress on changes in Continuous Performance Test (CPT) scores after MPH treatment were investigated.
Results:
Although there were no significant sites that showed significant association with treatment response, there was a significant interaction effect of the methylation of CpG7 and prenatal maternal stress on changes in omission errors of the CPT following treatment (p = 0.0001).
Conclusions:
The present findings indicate that the interaction between methylation of CpG7 of DRD4 and prenatal maternal stress may be predictive of the treatment response to MPH in youth with ADHD.
Get full access to this article
View all access options for this article.
References
1.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition-Text Revision. Washington, DC, American Psychiatric Association, 2000.
2.
AnierK, Malinovskaja\K, Aonurm-HelmA, ZharkovskyA, KaldaA: DNA methylation regulates cocaine-induced behavioral sensitization in mice. Neuropsychopharmacology, 35:2450–2461, 2010.
3.
BaierCJ, KatunarMR, AdroverE, PallaresME, AntonelliMC: Gestational restraint stress and the developing dopaminergic system: An overview. Neurotox Res, 22:16–32, 2012.
4.
Ben AmorL, GrizenkoN, SchwartzG, LageixP, BaronC, Ter-StepanianM, ZappitelliM, MbekouV, JooberR: Perinatal complications in children with attention-deficit hyperactivity disorder and their unaffected siblings. J Psychiatry Neurosci, 30:120–126, 2005.
5.
BergerMA, BarrosVG, SarchiMI, TaraziFI, AntonelliMC: Long-term effects of prenatal stress on dopamine and glutamate receptors in adult rat brain. Neurochem Res, 27:1525–1533, 2002.
6.
BuchmannAF, ZohselK, BlomeyerD, HohmE, HohmannS, Jennen-SteinmetzC, TreutleinJ, BeckerK, BanaschewskiT, SchmidtMH, EsserG, BrandeisD, PoustkaL, ZimmermannUS, LauchtM: Interaction between prenatal stress and dopamine D4 receptor genotype in predicting aggression and cortisol levels in young adults. Psychopharmacology, 231:3089–3097, 2014.
7.
CallawayE: Epigenomics starts to make its mark. Nature, 508:22, 2014.
8.
CheonKA, KimBN, ChoSC: Association of 4-repeat allele of the dopamine d4 receptor gene exon III polymorphism and response to methylphenidate treatment in korean ADHD children. Neuropsychopharmacology, 32:1377–1383, 2007.
9.
ContiniV, VictorMM, BertuzziGP, SalgadoCAI, PiconFA, GrevetEH, RohdeLA, Belmonte-De-AbreuP, BauCHD: No significant association between genetic variants in 7 candidate genes and response to methylphenidate treatment in adult patients with ADHD. J Clin Psychopharmacol, 32:820–823, 2012.
10.
CopogluUS, IgciM, BozgeyikE, KokacyaMH, IgciYZ, DokuyucuR, AriM, SavasHA: DNA methylation of BDNF gene in schizophrenia. Med Sci Monit, 22:397–402, 2016.
11.
DaddsMR, MoulC, HawesDJ, DiazAM, BrennanJ: Individual differences in childhood behavior disorders associated with epigenetic modulation of the cortisol receptor gene. Child Dev, 86:1311–1320, 2015.
12.
DingK, YangJ, ReynoldsGP, ChenB, ShaoJ, LiuR, QianQ, LiuH, YangR, WenJ, KangC: DAT1 methylation is associated with methylphenidate response on oppositional and hyperactive-impulsive symptoms in children and adolescents with ADHD. World J Biol Psychiatry, 18:291–299, 2017.
FrielingH, TadicA: Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment. Int Rev Psychiatry, 25:572–578, 2013.
18.
FroehlichTE, EpsteinJN, NickTG, CastroMSM, SteinMA, BrinkmanWB, GrahamAJ, LangbergJM, KahnRS: Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 50:1129–1139, 2011.
19.
GollMG, BestorTH: Eukaryotic cytosine methyltransferases. Annu Rev Biochem, 74:481–514, 2005.
20.
GrizenkoN, FortierME, ZadoroznyC, ThakurG, SchmitzN, DuvalR, JooberR: Maternal stress during pregnancy, ADHD symptomatology in children and genotype: Gene-environment interaction. J Can Acad Child Adolesc Psychiatry, 21:9–15, 2012.
21.
GrizenkoN, ShayanYR, PolotskaiaA, Ter-StepanianM, JooberR: Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci, 33:10–16, 2008.
22.
GuoJU, MaDK, MoH, BallMP, JangMH, BonaguidiMA, BalazerJA, EavesHL, XieB, FordE, ZhangK, MingGL, GaoY, SongH: Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci, 14:1345–1351, 2011.
23.
GuyW: ECDEU assessment manual for psychopharmacology, revised. Rockville, MD, US Deparment of Health, Education, and Welfare, 1976.
24.
HamarmanS, FossellaJ, UlgerC, BrimacombeM, DermodyJ: Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: A pharmacogenetic study. J Child Adolesc Psychopharmacol, 14:564–574, 2004.
25.
HanLY, LiuPP, WangCY, ZhongQL, FanR, WangL, DuanSW, ZhangLN: The interactions between alcohol consumption and DNA methylation of the ADD1 gene promoter modulate essential hypertension susceptibility in a population-based, case-control study. Hypertens Res, 38:284–290, 2015.
26.
HensleighE, PritchardLM: Glucocorticoid receptor expression and sub-cellular localization in dopamine neurons of the rat midbrain. Neurosci Lett, 556:191–195, 2013.
27.
HongSB, HarrisonBJ, FornitoA, SohnCH, SongIC, KimJW: Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder. J Psychiatry Neurosci, 40:46–57, 2015.
28.
HongSB, KimJW, ChoSC, ShinMS, KimBN, YooHJ: Dopaminergic and noradrenergic gene polymorphisms and response to methylphenidate in korean children with attention-deficit/hyperactivity disorder: Is there an interaction?. J Child Adolesc Psychopharmacol, 22:343–352, 2012.
29.
HoutepenLC, van BergenAH, VinkersCH, BoksMPM: DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder. Epigenomics, 8:197–208, 2016.
30.
JonesPA, BaylinSB: The fundamental role of epigenetic events in cancer. Nat Rev Genet, 3:415–428, 2002.
31.
KaufmanJ, BirmaherB, BrentD, RaoU, FlynnC, MoreciP, WilliamsonD, RyanN: Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. J Am Acad Child Adolesc Psychiatry, 36:980–988, 1997.
32.
KielingC, GenroJP, HutzMH, RohdeLA: A current update on ADHD pharmacogenomics. Pharmacogenomics, 11:407–419, 2010.
33.
KimB, KooMS, JunJY, ParkIH, OhDY, CheonKA: Association between dopamine D4 receptor gene polymorphism and scores on a continuous performance test in Korean children with attention deficit hyperactivity disorder. Psychiatry Investig, 6:216–221, 2009.
34.
KimJW, SharmaV, RyanND: Predicting methylphenidate response in ADHD using machine learning approaches. Int J Neuropsychopharmacol, 18:pyv052, 2015.
35.
KimYS, CheonKA, KimBN, ChangSA, YooHJ, KimJW, ChoSC, SeoDH, BaeMO, SoYK, NohJS, KohYJ, McBurnettK, LeventhalB: The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version-Korean version (K-SADS-PL-K). Yonsei Med J, 45:81–89, 2004.
36.
LichterJB, BarrCL, KennedyJL, VantolHHM, KiddKK, LivakKJ: A hypervariable segment in the human dopamine receptor D(4) (DRD4) gene. Hum Mol Genet, 2:767–773, 1993.
37.
McGowanPO, SasakiA, D'AlessioAC, DymovS, LabonteB, SzyfM, TureckiG, MeaneyMJ: Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci, 12:342–348, 2009.
NiggJ, NikolasM, BurtSA: Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry, 49:863–873, 2010.
41.
O'DonnellKJ, JensenAB, FreemanL, KhalifeN, O'ConnorTG, GloverV: Maternal prenatal anxiety and downregulation of placental 11β-HSD2. Psychoneuroendocrinology, 37:818–826, 2012.
42.
OberlanderTF, WeinbergJ, PapsdorfM, GrunauR, MisriS, DevlinAM: Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics, 3:97–106, 2008.
43.
OhJE, ChambweN, KleinS, GalJ, AndrewsS, GleasonG, ShaknovichR, MelnickA, CampagneF, TothM: Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment. Transl Psychiatry, 3:e218, 2013.
44.
PagerolsM, RicharteV, Sanchez-MoraC, Garcia-MartinezI, CorralesM, CorominasM, CormandB, CasasM, RibasesM, Ramos-QuirogaJA: Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder. Pharmacogenomics J, 17:98–104, 2017.
45.
ParkKS, YoonYJ, ParkHJ, KwonKU. Development of Kedi-Wsic, Individual Intelligence Test for Korean Children. Seoul, Korean Educational Development Institute, 1996.
46.
ParkS, ChoSC, KimJW, ShinMS, YooHJ, OhSM, HanDH, CheongJH, KimBN: Differential perinatal risk factors in children with attention-deficit/hyperactivity disorder by subtype. Psychiatry Res, 219:609–616, 2014.
47.
RodriguezA, BohlinG: Are maternal smoking and stress during pregnancy related to ADHD symptoms in children?. J Child Psychol Psychiatry, 46:246–254, 2005.
SchachterHA, KingJ, LangfordS, MoherD: How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents?. A meta-analysis. Can Med Assoc J, 165:1475–1488, 2001.
50.
SeegerG, SchlossP, SchmidtMH: Marker gene polymorphisms in hyperkinetic disorder—Predictors of clinical response to treatment with methylphenidate?. Neurosci Lett, 313:45–48, 2001.
51.
ShinMS, ChoSC, ChunSY, HongKE: A study of the development and standardization of ADHD diagnostic system. Korean J Child Adolesc Psychiatry, 41:612–618, 2000.
52.
SooH, PaikKC, ParkWS, LimMH: No association between the response to methylphenidate and DRD4 gene polymorphism in Korean attention deficit hyperactivity disorder: A case control study. Clin Psychopharmacol Neurosci, 11:13–17, 2013.
53.
TangH, DaltonCF, SrisawatU, ZhangZJ, ReynoldsGP: Methylation at a transcription factor-binding site on the 5-HT1a receptor gene correlates with negative symptom treatment response in first episode schizophrenia. Int J Neuropsychopharmacol, 17:645–649, 2014.
54.
Van den BerghBR, MarcoenA: High antenatal maternal anxiety is related to adhd symptoms, externalizing problems, and anxiety in 8- and 9-year-olds. Child Dev, 75:1085–1097, 2004.
55.
van MilNH, Steegers-TheunissenRPM, Bouwland-BothMI, VerbiestMMPJ, RijlaarsdamJ, HofmanA, SteegersEAP, HeijmansBT, JaddoeVWV, VerhulstFC, StolkL, EilersPHC, UitterlindenAG, TiemeierH: DNA methylation profiles at birth and child ADHD symptoms. J Psychiatr Res, 49:51–59, 2014.
WermterAK, LauchtM, SchimmelmannBG, BanaschewskiT, Sonuga-BarkeEJ, RietschelM, BeckerK: From nature versus nurture, via nature and nurture, to gene x environment interaction in mental disorders. Eur Child Adolesc Psychiatry, 19:199–210, 2010.
58.
WilensTE: Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol, 28:S46–S53, 2008.
59.
XuY, ChenXT, LuoM, TangYQ, ZhangGX, WuD, YangB, RuanDY, WangHL: Multiple epigenetic factors predict the attention deficit/hyperactivity disorder among the Chinese Han children. J Psychiatr Res, 64:40–50, 2015.
60.
ZohselK, BuchmannAF, BlomeyerD, HohmE, SchmidtMH, EsserG, BrandeisD, BanaschewskiT, LauchtM: Mothers' prenatal stress and their children's antisocial outcomes—A moderating role for the dopamine receptor D4 (DRD4) gene. J Child Psychol Psychiatry, 55:69–76, 2014.
61.
ZucchiFCR, YaoYL, WardID, IlnytskyyY, OlsonDM, BenziesK, KovalchukI, KovalchukO, MetzGAS: Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring. PLoS One, 8:e56967, 2013.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
